DoxyPEP Tied to Decreases in Sexually Transmitted Infections
By Lori Solomon HealthDay Reporter
TUESDAY, Jan. 7, 2025 -- Doxycycline postexposure prophylaxis (doxyPEP) initiation is associated with decreases in sexually transmitted infections (STIs), according to a study published online Jan. 6 in JAMA Internal Medicine.
Michael W. Traeger, Ph.D., from Harvard Pilgrim Health Care Institute in Boston, and colleagues described early uptake of doxyPEP and evaluated changes in STI incidence following doxyPEP initiation. The analysis included data from 11,551 adults dispensed HIV preexposure prophylaxis (PrEP) at Kaiser Permanente Northern California from Nov. 1, 2022, to Dec. 31, 2023.
The researchers found that 19.5 percent were dispensed doxyPEP, which was associated with older age (mean age, 40.4 versus 39.8 years), longer HIV PrEP use (mean, 4.2 versus 3.4 years), and a higher proportion of commercial insurance (92.8 versus 88.9 percent). Quarterly chlamydia positivity decreased from 9.6 percent before starting doxyPEP to 2.0 percent after starting doxyPEP (rate ratio [RR], 0.21), with significant declines for each anatomic site of infection. Similarly, quarterly gonorrhea positivity decreased from 10.2 percent before starting doxyPEP to 9.0 percent afterward (RR, 0.88), with significant site-specific declines seen for rectal (RR, 0.81) and urethral (RR, 0.56) gonorrhea. Lastly, quarterly syphilis positivity decreased from 1.7 percent before starting doxyPEP to 0.3 percent afterward (RR, 0.20). Among individuals not dispensed doxyPEP, positivity for STIs remained stable.
"These findings suggest that doxyPEP may offer substantial benefits for reducing population-level STI transmission with broader implementation," the authors write.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Younger People Open to Self-Collected Testing for Sexually Transmitted Infections
THURSDAY, Feb. 20, 2025 -- Self-collected testing for sexually transmitted infections (STIs) appears to be acceptable to adolescents and young adults, according to a study...
Global Study Reveals High Rates of Sexual Violence Against Children
TUESDAY, Jan. 14, 2025 -- Lifetime sexual harassment has a pooled rate of 11.4 percent among children, while contact sexual violence has a rate of 8.7 percent, according to a...
USPSTF Recommends Early Screening for Syphilis in Pregnancy
TUESDAY, Nov. 19, 2024 -- The U.S. Preventive Services Task Force (USPSTF) recommends early screening for syphilis infection in all pregnant women (grade A recommendation). This...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.